Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shares were up 1.4% on Monday . The company traded as high as $40.9850 and last traded at $40.72. Approximately 1,268 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 3,001 shares. The stock had previously closed at $40.14.
Hikma Pharmaceuticals Price Performance
The business has a 50-day moving average of $44.18 and a 200-day moving average of $48.80.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Which Wall Street Analysts are the Most Accurate?
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- What is Forex and How Does it Work?
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- How to Calculate Return on Investment (ROI)
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
